Related Experiment Videos
Inflammatory bowel disease in pediatric patients
1Department of Radiology, Children's Hospital of Pittsburgh, University of Pittsburgh, USA.
Summary
Technetium Tc-99m HMPAO-labeled white blood cell (99mTc-HMPAO-WBC) scans accurately detect and localize pediatric inflammatory bowel disease. This noninvasive nuclear medicine procedure aids in diagnosis, differentiating Crohn
Area of Science:
- Nuclear Medicine
- Pediatric Gastroenterology
- Inflammatory Bowel Disease Diagnostics
Background:
- Optimal management of pediatric inflammatory bowel disease (IBD) necessitates precise localization and intensity assessment.
- Current diagnostic methods may be invasive or less accurate for certain IBD presentations.
Purpose of the Study:
- To evaluate the diagnostic accuracy and clinical utility of 99mTc-HMPAO-WBC scintigraphy in children with IBD.
- To compare the efficacy of 99mTc-HMPAO-WBC scans with established diagnostic modalities.
Main Methods:
- Prospective evaluation of over 230 children with suspected or diagnosed IBD.
- Utilized 99mTc-HMPAO-WBC scintigraphy as a noninvasive nuclear medicine imaging technique.
- Correlated scan findings with endoscopic, radiologic, surgical, and laboratory data.
Main Results:
- High concordance between 99mTc-HMPAO-WBC scan findings and conventional diagnostic methods for disease distribution.
- Demonstrated ability to identify extra-intestinal inflammation and differentiate Crohn's disease from ulcerative colitis.
- Scan intensity correlated better with erythrocyte sedimentation rate than clinical activity index, influencing treatment adjustments.
Conclusions:
- 99mTc-HMPAO-WBC scintigraphy is a reliable, safe, and noninvasive tool for IBD detection, localization, and characterization in children.
- The procedure requires no bowel preparation and offers excellent diagnostic accuracy, making it valuable for initial evaluation and follow-up.
- Findings support the integration of 99mTc-HMPAO-WBC scans into routine pediatric IBD management.